1. Home
  2. TRDA vs FDUS Comparison

TRDA vs FDUS Comparison

Compare TRDA & FDUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRDA
  • FDUS
  • Stock Information
  • Founded
  • TRDA 2016
  • FDUS 2011
  • Country
  • TRDA United States
  • FDUS United States
  • Employees
  • TRDA N/A
  • FDUS N/A
  • Industry
  • TRDA Biotechnology: Pharmaceutical Preparations
  • FDUS Finance/Investors Services
  • Sector
  • TRDA Health Care
  • FDUS Finance
  • Exchange
  • TRDA Nasdaq
  • FDUS Nasdaq
  • Market Cap
  • TRDA 609.7M
  • FDUS 664.9M
  • IPO Year
  • TRDA 2021
  • FDUS 2011
  • Fundamental
  • Price
  • TRDA $17.63
  • FDUS $19.73
  • Analyst Decision
  • TRDA Strong Buy
  • FDUS Hold
  • Analyst Count
  • TRDA 3
  • FDUS 1
  • Target Price
  • TRDA $21.67
  • FDUS $22.00
  • AVG Volume (30 Days)
  • TRDA 166.9K
  • FDUS 188.7K
  • Earning Date
  • TRDA 11-05-2024
  • FDUS 10-31-2024
  • Dividend Yield
  • TRDA N/A
  • FDUS 12.46%
  • EPS Growth
  • TRDA N/A
  • FDUS 85.86
  • EPS
  • TRDA 3.04
  • FDUS 3.20
  • Revenue
  • TRDA $239,397,000.00
  • FDUS $140,811,000.00
  • Revenue This Year
  • TRDA $39.06
  • FDUS $12.77
  • Revenue Next Year
  • TRDA N/A
  • FDUS $3.76
  • P/E Ratio
  • TRDA $5.76
  • FDUS $6.16
  • Revenue Growth
  • TRDA 451.22
  • FDUS 25.63
  • 52 Week Low
  • TRDA $10.75
  • FDUS $17.63
  • 52 Week High
  • TRDA $18.17
  • FDUS $20.60
  • Technical
  • Relative Strength Index (RSI)
  • TRDA 61.79
  • FDUS 55.51
  • Support Level
  • TRDA $15.65
  • FDUS $19.44
  • Resistance Level
  • TRDA $18.01
  • FDUS $19.59
  • Average True Range (ATR)
  • TRDA 0.75
  • FDUS 0.16
  • MACD
  • TRDA 0.17
  • FDUS 0.03
  • Stochastic Oscillator
  • TRDA 86.52
  • FDUS 95.74

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

About FDUS Fidus Investment Corporation

Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investments is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.

Share on Social Networks: